BETA: Please send your feedback!
Scythian Biosciences
SCYB-CA:TSX
Miscellaneous Commercial Services
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 4
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Miscellaneous Commercial Services
Founded null
Scythian Biosciences Corp. engages in development of drug therapies. It specializes in the development of a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. It also intends to develop other potential cannabinoid and non-cannabinoid based pharmaceutical products, including one that is in development for treatment of gastro-inflammatory disease. The company is headquartered in Toronto, Canada.
website
Headquarters
Executives
Name | Title | Gender |
Mindful Investing Summary
Scythian Biosciences - Competitors and Related Companies
How Scythian Biosciences stacks up to its peers in the Miscellaneous Commercial Services industry or with competing business segments.
Scythian Biosciences
SCYB-CA:TSX
Miscellaneous Commercial Services
—
MICRO cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…